S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
S&P 500   4,397.94 (-1.89%)
DOW   34,265.37 (-1.30%)
QQQ   351.69 (-2.77%)
AAPL   162.41 (-1.28%)
MSFT   296.03 (-1.85%)
FB   303.17 (-4.23%)
GOOGL   2,607.03 (-2.22%)
AMZN   2,852.86 (-5.95%)
TSLA   943.90 (-5.26%)
NVDA   233.74 (-3.21%)
BABA   123.23 (-5.95%)
NIO   27.35 (-6.11%)
AMD   118.81 (-2.53%)
CGC   7.29 (-3.57%)
MU   81.93 (-3.69%)
GE   96.30 (-1.98%)
T   26.61 (-1.52%)
F   20.65 (-4.62%)
DIS   137.38 (-6.94%)
AMC   17.97 (-0.55%)
PFE   52.79 (-2.33%)
ACB   4.46 (-6.11%)
BA   205.44 (-4.09%)
NYSE:TBI

TrueBlue Stock Forecast, Price & News

$26.84
+0.01 (+0.04%)
(As of 01/21/2022 12:00 AM ET)
Add
Compare
Today's Range
$26.41
$27.72
50-Day Range
$26.02
$29.30
52-Week Range
$18.54
$32.91
Volume
162,655 shs
Average Volume
166,397 shs
Market Capitalization
$952.31 million
P/E Ratio
19.04
Dividend Yield
N/A
Beta
1.54
30 days | 90 days | 365 days | Advanced Chart
Receive TBI News and Ratings via Email

Sign-up to receive the latest news and ratings for TrueBlue and its competitors with MarketBeat's FREE daily newsletter.


TrueBlue logo

About TrueBlue

TrueBlue, Inc. engages in the provision of staffing, recruitment process outsourcing and managed service provider solutions. It operates through the following segments: PeopleReady, PeopleManagement and PeopleScout. The PeopleReady segment offers staffing solutions for blue-collar, contingent on-demand and skilled labor to a broad range of industries that include retail, manufacturing, warehousing, logistics, energy, construction, hospitality and others. The PeopleManagement segment supplies contingent labor and outsourced industrial workforce solutions. The PeopleScout segment covers the provision of permanent employee recruitment process outsourcing for its customers for all major industries and jobs. The company was founded by John Ross Coghlan and Glenn Welstad in 1989 and is headquartered in Tacoma, WA.

Headlines

TrueBlue (NYSE:TBI) Trading Down 2.6%
January 20, 2022 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Industry
Help supply services
Sub-Industry
Human Resource & Employment Services
CUSIP
89785X10
Employees
5,200
Year Founded
N/A

Sales & Book Value

Annual Sales
$1.85 billion
Cash Flow
$5.75 per share
Book Value
$12.32 per share

Profitability

Net Income
$-141.84 million
Pretax Margin
2.87%

Debt

Price-To-Earnings

Miscellaneous

Free Float
34,771,000
Market Cap
$952.31 million
Optionable
Optionable

Company Calendar

Last Earnings
10/24/2021
Today
1/21/2022
Next Earnings (Confirmed)
2/02/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

1.45 out of 5 stars

Business Services Sector

326th out of 453 stocks

Help Supply Services Industry

20th out of 20 stocks

Analyst Opinion: 1.3Community Rank: 4.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -












TrueBlue (NYSE:TBI) Frequently Asked Questions

Is TrueBlue a buy right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for TrueBlue in the last twelve months. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TrueBlue stock.
View analyst ratings for TrueBlue
or view top-rated stocks.

How has TrueBlue's stock been impacted by COVID-19?

TrueBlue's stock was trading at $13.35 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TBI stock has increased by 101.0% and is now trading at $26.84.
View which stocks have been most impacted by COVID-19
.

When is TrueBlue's next earnings date?

TrueBlue is scheduled to release its next quarterly earnings announcement on Wednesday, February 2nd 2022.
View our earnings forecast for TrueBlue
.

How can I listen to TrueBlue's earnings call?

TrueBlue will be holding an earnings conference call on Wednesday, February 2nd at 5:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were TrueBlue's earnings last quarter?

TrueBlue, Inc. (NYSE:TBI) issued its quarterly earnings results on Sunday, October, 24th. The business services provider reported $0.59 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.60 by $0.01. The business services provider had revenue of $577.03 million for the quarter, compared to analyst estimates of $570.85 million. TrueBlue had a trailing twelve-month return on equity of 12.55% and a net margin of 2.39%. TrueBlue's revenue for the quarter was up 21.6% on a year-over-year basis. During the same period last year, the firm posted $0.24 EPS.
View TrueBlue's earnings history
.

What price target have analysts set for TBI?

3 equities research analysts have issued 12-month price objectives for TrueBlue's shares. Their forecasts range from $23.00 to $35.00. On average, they expect TrueBlue's stock price to reach $29.00 in the next twelve months. This suggests a possible upside of 8.0% from the stock's current price.
View analysts' price targets for TrueBlue
or view top-rated stocks among Wall Street analysts.

Who are TrueBlue's key executives?

TrueBlue's management team includes the following people:
  • A. Patrick Beharelle, President, Chief Executive Officer & Director
  • Derrek L. Gafford, Chief Financial Officer & Executive Vice President (LinkedIn Profile)
  • Jeffrey S. Dirks, Chief Information & Technology Officer
  • Garrett R. Ferencz, Chief Legal Officer & Executive Vice President
  • Richard Christensen, Chief Accounting Officer & Senior Vice President

What is Patrick Beharelle's approval rating as TrueBlue's CEO?

34 employees have rated TrueBlue CEO Patrick Beharelle on Glassdoor.com. Patrick Beharelle has an approval rating of 56% among TrueBlue's employees. This puts Patrick Beharelle in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of TrueBlue own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TrueBlue investors own include International Business Machines (IBM), Intel (INTC), NVIDIA (NVDA), Vertex Pharmaceuticals (VRTX), Gilead Sciences (GILD), The Goldman Sachs Group (GS), AT&T (T), Zynga (ZNGA), AbbVie (ABBV) and Amgen (AMGN).

What is TrueBlue's stock symbol?

TrueBlue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Who are TrueBlue's major shareholders?

TrueBlue's stock is owned by many different retail and institutional investors. Top institutional investors include Russell Investments Group Ltd. (0.31%), State of Alaska Department of Revenue (0.07%), Diversified Trust Co (0.04%), Crossmark Global Holdings Inc. (0.03%) and Parallel Advisors LLC (0.01%). Company insiders that own TrueBlue stock include A Patrick Beharelle, Carl Schweihs, Colleen B Brown, Derrek Lane Gafford, Richard Christensen, Steven C Cooper and Taryn R Owen.
View institutional ownership trends for TrueBlue
.

Which major investors are selling TrueBlue stock?

TBI stock was sold by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., Diversified Trust Co, Parallel Advisors LLC, and State of Alaska Department of Revenue. Company insiders that have sold TrueBlue company stock in the last year include A Patrick Beharelle, Carl Schweihs, Derrek Lane Gafford, Richard Christensen, Steven C Cooper, and Taryn R Owen.
View insider buying and selling activity for TrueBlue
or view top insider-selling stocks.

Which major investors are buying TrueBlue stock?

TBI stock was purchased by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc..
View insider buying and selling activity for TrueBlue
or or view top insider-buying stocks.

How do I buy shares of TrueBlue?

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TrueBlue's stock price today?

One share of TBI stock can currently be purchased for approximately $26.84.

How much money does TrueBlue make?

TrueBlue has a market capitalization of $952.31 million and generates $1.85 billion in revenue each year. The business services provider earns $-141.84 million in net income (profit) each year or $1.41 on an earnings per share basis.

How many employees does TrueBlue have?

TrueBlue employs 5,200 workers across the globe.

What is TrueBlue's official website?

The official website for TrueBlue is www.trueblue.com.

Where are TrueBlue's headquarters?

TrueBlue is headquartered at 1015 A STREET, TACOMA WA, 98402.

How can I contact TrueBlue?

TrueBlue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at (253) 383-9101, via email at [email protected], or via fax at 877-733-0399.


This page was last updated on 1/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.